Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.5%

116 terminated/withdrawn out of 1101 trials

Success Rate

83.1%

-3.4% vs industry average

Late-Stage Pipeline

101 trials in Phase 3/4

Results Transparency

49%

276 of 569 completed trials have results

Key Signals

146 recruiting276 with results57 terminated59 withdrawn

Enrollment Performance

Analytics

N/A

399(58.6%)

Phase 2

96(14.1%)

Phase 1

78(11.5%)

Phase 4

63(9.3%)

Phase 3

38(5.6%)

Early Phase 1

7(1.0%)

681Total

N/A(399)

Phase 2(96)

Phase 1(78)

Phase 4(63)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1101)

Showing 20 of 1101 trials

NCT03979014Phase 3Completed

Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia

Role: lead

NCT03752333Phase 2Completed

Trial of Pembrolizumab in Cancer of Unknown Primary

Role: lead

NCT04358185Phase 1Completed

Itacitinib in Advanced Hepatocellular Carcinoma

Role: lead

NCT06230354Phase 2Active Not Recruiting

Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis

Role: lead

NCT07555795Not ApplicableRecruiting

Motivating Core-muscle Exercises With Wearable Sensors, Haptics and Interactive Gaming

Role: lead

NCT05735639Phase 4Recruiting

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Role: lead

NCT05213806Not ApplicableRecruiting

WithHolding Enteral Feeds Around Blood Transfusion (International)

Role: collaborator

NCT07431021Not ApplicableRecruiting

Children's Health, Respiratory Inflammation and Short-term Air Pollution

Role: collaborator

NCT06620185Not ApplicableRecruiting

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

Role: lead

NCT04765644Phase 4Completed

Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment

Role: lead

NCT06896799Not ApplicableRecruiting

Determining the Effect of Food Ordering on Blood Glucose In Gestational Diabetes Mellitus (DEFI-GDM)

Role: collaborator

NCT07532785Not ApplicableNot Yet Recruiting

Feasibility of Good Boost+ for Adults Awaiting Total Knee Replacement

Role: collaborator

NCT04355156Phase 2Completed

Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancer

Role: lead

NCT07264088Not Yet Recruiting

Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer

Role: lead

NCT06181708Completed

Diagnostics in the Leg Ulcer Pathway

Role: lead

NCT07112235Recruiting

Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets

Role: lead

NCT07191678Recruiting

Mechanisms Affecting the Gut of Preterm Infants Receiving Blood Transfusion With Different Enteral Feed Interventions

Role: collaborator

NCT05808543Not ApplicableRecruiting

BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants

Role: collaborator

NCT05646082Phase 1Active Not Recruiting

Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma

Role: lead

NCT04620538Completed

Volatile Organic Compounds for the Assessment of Liver Disease

Role: lead